Medical Condition News

RSS

Researchers look for surrogate endpoints to predict early benefit of cancer drugs

Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing. Researchers are therefore looking for proxy markers that after initiation of cancer therapy can reliably predict as quickly as possible whether the treatment has a benefit.

12 May 2011

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

INESC Porto and FEUP developed software to automatically analyse and validate mammograms. The software, Semantic PACS, can be incorporated into hospital IT systems and it categorises each new mammography using automatic descriptive methods and search methods that compare the semantic contents of the images stored.

12 May 2011

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

The University of Manchester, GlaxoSmithKline and AstraZeneca announce today the creation of the Manchester Collaborative Centre for Inflammation Research, a unique collaboration to establish a world-leading translational centre for inflammatory diseases. The project starts out with an initial investment of -5M from each partner over a three year period.

From The University of Manchester 12 May 2011

INESC Porto, FC and FMUP to hold international seminar on breast cancer local treatment

The international seminar "Turning Subjective Into Objective: Cosmetic Breast Assessment of Local Treatment" will take place on 13th May starting at 9.15am. The event is organised by the Champalimaud Foundation, the Faculty of Medicine of the University of Porto and the Institute for Systems and Computer Engineering of Porto.

12 May 2011

Two new research studies on schizophrenia

Two new research studies published in Biological Psychiatry point to progressive abnormalities in brain development that emerge as vulnerable individuals develop schizophrenia.

12 May 2011

Healthy alternatives to vitamin D

The recent increase in recommended vitamin D intake from the Food and Nutrition Board may prompt some to seek more summer sun. But, experts at The University of Texas MD Anderson Cancer Center say there's no safe amount of time people can stay in the sun without increasing skin cancer risks.

12 May 2011

iPSC-derived liver cells hold potential as alternative to liver transplants

Johns Hopkins researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.

12 May 2011

Reprogrammed herpes virus can improve early cancer diagnosis

Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence.

12 May 2011

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people.

12 May 2011

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

For diagnosing head and neck ailments, tests that use radiation are always less desirable than those that don't. Otolaryngologists have a wide range of techniques available to them, including CT or "CAT" scans, MRI and ultrasound.

12 May 2011

Being mildly overweight benefits ALS patients

Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be an exception to the rule that being overweight is a health hazard. In a retrospective study of over 400 ALS patients, Massachusetts General Hospital researchers found that those who were mildly obese survived longer than patients who were normal weight, underweight or even overweight.

12 May 2011

FDA accepts EffRx NDA for EX101 to treat osteoporosis

EffRx Pharmaceuticals SA, an Epalinges/Lausanne, Switzerland based drug delivery company announces that the New Drug Application for the company's lead development program EX101 has been accepted for filing by the US Food and Drug Administration.

12 May 2011

Increased automobile usage linked with surging levels of obesity

Junk food, video games and a lack of exercise all have received their fair share of blame for the spiraling epidemic of obesity in the U.S. But according to a University of Illinois researcher, public health enemy No. 1 for our supersized nation may very well be the one staple of modern life most Americans can't seem to live without one (or more) of: the automobile.

12 May 2011

Nicotine-free plastic inhalers may increase smoker's chance of quitting

Nicotine-free plastic inhalers may increase a smoker's chance of quitting, according to new research published online in the European Respiratory Journal.

12 May 2011

Neogenix Oncology to receive European Patent for NEO-301 antibody for treatment of pancreatic cancer

Neogenix Oncology is pleased to announce that it will be granted a European Patent relating to its NEO-301 antibody, to take effect beginning September 23, 2011.

12 May 2011

FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain

Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.

12 May 2011

ViroPharma, Halozyme sign license deal to develop Cinryze against hereditary angioedema

Halozyme Therapeutics, Inc. and ViroPharma Incorporated, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous formulation of Cinryze .

12 May 2011

Visual perception and attention can be changed by passive stimulation

What was previously known from animal studies has thus for the first time been demonstrated for human individuals too. "The findings open new perspectives in the intervention and treatment of visual perceptual disorders, because the changes can be induced quite simply" said Dr. Christian Beste of the RUB Institute of Cognitive Neuroscience.

12 May 2011

School-based prevention programs can help reduce alcohol problems in young people

School prevention programs aimed at curbing alcohol misuse in children are somewhat helpful, enough so to deserve consideration for widespread use, according to a large, international systematic review.

12 May 2011

Scientists to discuss latest autism research findings at IMFAR meeting

The 10th Annual International Meeting for Autism Research will host more than 1900 researchers, delegates, autism specialists, and students in the world's largest gathering of researchers and clinicians devoted to a better understanding of autism. The meeting will be held at the Manchester Grand Hyatt from May 12-14, 2011.

12 May 2011

Medical Condition News

Researchers look for surrogate endpoints to predict early benefit of cancer drugs

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

INESC Porto, FC and FMUP to hold international seminar on breast cancer local treatment

Two new research studies on schizophrenia

Healthy alternatives to vitamin D

iPSC-derived liver cells hold potential as alternative to liver transplants

Reprogrammed herpes virus can improve early cancer diagnosis

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

Being mildly overweight benefits ALS patients

FDA accepts EffRx NDA for EX101 to treat osteoporosis

Increased automobile usage linked with surging levels of obesity

Nicotine-free plastic inhalers may increase smoker's chance of quitting

Neogenix Oncology to receive European Patent for NEO-301 antibody for treatment of pancreatic cancer

FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain

ViroPharma, Halozyme sign license deal to develop Cinryze against hereditary angioedema

Visual perception and attention can be changed by passive stimulation

School-based prevention programs can help reduce alcohol problems in young people

Scientists to discuss latest autism research findings at IMFAR meeting

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News